Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). (2014)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jbmr.2023
PubMed Identifier: 23794198
Publication URI: http://europepmc.org/abstract/MED/23794198
Type: Journal Article/Review
Volume: 29
Parent Publication: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Issue: 1
ISSN: 0884-0431